State Street Corporation 13D and 13G filings for CLOVIS ONCOLOGY INC:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-04-11 1:58 pm Sale | 2022-03-31 | 13G | CLOVIS ONCOLOGY INC CLVSQ | STATE STREET CORP STT | 2,619,477 1.840% | -13,495,065 (-83.74%) | Filing |
| 2022-02-11 07:57 am Purchase | 2021-12-31 | 13G | CLOVIS ONCOLOGY INC CLVSQ | STATE STREET CORP STT | 16,114,542 12.400% | 5,655,198 (+54.07%) | Filing |
| 2021-06-10 10:13 am Purchase | 2021-05-31 | 13G | CLOVIS ONCOLOGY INC CLVSQ | STATE STREET CORP STT | 10,459,344 10.000% | 566,467 (+5.73%) | Filing |
| 2021-04-12 11:52 am Sale | 2021-03-31 | 13G | CLOVIS ONCOLOGY INC CLVSQ | STATE STREET CORP STT | 9,892,877 9.460% | -4,642,995 (-31.94%) | Filing |
| 2021-02-11 2:38 pm Unchanged | 2020-12-31 | 13G | CLOVIS ONCOLOGY INC CLVSQ | STATE STREET CORP STT | 14,535,872 16.460% | 0 (Unchanged) | Filing |
| 2021-01-11 10:01 am Purchase | 2020-12-31 | 13G | CLOVIS ONCOLOGY INC CLVSQ | STATE STREET CORP STT | 14,535,872 16.460% | 5,297,141 (+57.34%) | Filing |
| 2020-07-10 11:05 am Purchase | 2020-06-30 | 13G | CLOVIS ONCOLOGY INC CLVSQ | STATE STREET CORP STT | 9,238,731 10.510% | 5,577,282 (+152.32%) | Filing |
| 2020-02-13 08:26 am Sale | 2019-12-31 | 13G | CLOVIS ONCOLOGY INC CLVSQ | STATE STREET CORP STT | 3,661,449 6.680% | -1,672,200 (-31.35%) | Filing |